Innovative Approach to Clinical Trial Services
McKesson's Pharmacy Management Solutions, particularly in the realm of Clinical Trial Services, are at the forefront of revolutionizing the landscape of oncology research. Partnering with Sarah Cannon Research Institute (SCRI), McKesson offers a comprehensive suite of services aimed at addressing the complexities associated with clinical trial design and execution. By collaborating with SCRI, biopharmaceutical companies can expedite patient access to new cancer care therapies.
Leadership in Oncology Research
Sarah Cannon Research Institute, a key player in the oncology research domain, has been a pivotal force in advancing patient therapies for over three decades. Having conducted more than 750 first-in-human clinical trials, SCRI has significantly contributed to the approval of a majority of the new cancer therapies by the FDA. Through its strategic partnerships with leading biopharmaceutical companies, SCRI conducts community-based research spanning early to late-stage clinical trials, showcasing their commitment to shaping the future of oncology treatment.
Scope of Services
With a vast research network comprising over 1,300 physicians actively engaged in more than 1,000 clinical trials across 250 locations in 24 U.S. states, SCRI offers an unmatched platform for advancing oncology research. The personalized medicine program by SCRI translates real-world data into actionable insights, enhancing the efficiency and efficacy of clinical trials. Additionally, SCRI's Clinical Trial Access program focuses on improving trial diversity, ensuring that all patient populations have equitable access to cutting-edge treatments.
Commitment to Clinical Excellence
At the core of SCRI's philosophy is the belief that participation in clinical trials should be the primary choice in the battle against cancer, rather than a last resort. This commitment to clinical excellence underscores SCRI's dedication to transforming the landscape of oncology research and bringing pioneering therapies to patients in need. By partnering with McKesson's Pharmacy Management Solutions, biopharmaceutical companies can harness the expertise and resources of SCRI to drive innovation and accelerate the development of life-saving treatments.